how much weight does the average person lose on semaglutide Two-year effects of in adults with overweight or obesity: STEP 5 trial Semaglutide - Renew Body Wellness

Bone Health Concerns (Osteoporosis) One of the most serious but under-discussed long-term risks of GLP-1 medications is their potential impact on bone health

If they do, read and follow the instructions to dispense the medication

They are used in T2DM, obesity, and increasingly in cardiovascular risk reduction

Your Klinic provider will perform an in-depth evaluation to determine your eligibility, ensuring the best outcomes

Your provider will recommend the schedule thats best for you

Patients with a history of multiple endocrine neoplasia syndrome type 2 (MEN2) also cannot safely receive semaglutide, as this genetic condition increases MTC risk substantially